Mira Pharmaceuticals Inc (MIRA)
0.8799 -0.0701 (-7.38%) 12:41 ET [NASDAQ]
0.8750 x 2 0.8799 x 1
Realtime by (Cboe BZX)
0.8750 x 2 0.8799 x 1
Realtime 0.9899 +0.0419 (-) 08:00 ET
for Thu, Apr 3rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | |
Cash Flows From Operating Activities | |||
Net Income | -7,853 | -11,982 | -7,058 |
Other Working Capital | 371 | -640 | 147 |
Other Operating Activity | 1,921 | 8,090 | 1,307 |
Operating Cash Flow | $-5,561 | $-4,532 | $-5,605 |
Cash Flows From Investing Activities | |||
Investing Cash Flow | $N/A | $N/A | $N/A |
Cash Flows From Financing Activities | |||
Change In Short Term Borrowing | N/A | 2,148 | N/A |
Common Stock Issued | 3,609 | 7,704 | 2,904 |
Other Financing Activity | 182 | -1,068 | 242 |
Financing Cash Flow | $3,791 | $8,784 | $3,146 |
Beginning Cash Position | 4,603 | 351 | 2,810 |
End Cash Position | 2,833 | 4,603 | 351 |
Net Cash Flow | $-1,770 | $4,252 | $-2,459 |
Free Cash Flow | |||
Operating Cash Flow | -5,561 | -4,532 | -5,605 |
Free Cash Flow | -5,561 | -4,532 | -5,605 |